MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


AstraZeneca prices €800m fixed rate notes

StockMarketWire.com

Pharma giant AstraZeneca said it had priced its €800 million fixed rate notes with a coupon of 0.375% that will mature on 3 June 2029.

AstraZeneca expected to use the net proceeds of the offering to fund a portion of the purchase price for the Alexion acquisition, and for general corporate purposes.

The notes would be subject to 'special mandatory redemption if the acquisition of Alexion Pharmaceuticals is not consummated on or before 12 March 2022 or, if prior to such date, AstraZeneca notifies the trustee that AstraZeneca will not pursue the consummation of the Alexion Acquisition,' the company said.





Story provided by StockMarketWire.com